American Healthcare REIT (NYSE: AHR) CIO logs RSU vesting, tax share withholding

(Neutral)

Form Type

Rhea-AI Filing Summary

American Healthcare REIT, Inc. Chief Investment Officer Stefan K.L. Oh reported routine equity compensation activity involving restricted stock units and common stock. On March 25, 2026, 9,151 and 5,086 restricted stock units converted into the same number of common shares as scheduled vesting events.

The company withheld 4,657 and 2,588 common shares, valued at $48.25 per share, to cover Mr. Oh’s tax obligations tied to these vestings, which are not open‑market sales. He also received a new grant of 9,510 time‑based restricted stock units. Following these transactions, he holds 95,430 common shares directly.

Insider Trade Summary

Net Buyer: 6,992 shares

Net Buy 7 txns

Insider Oh Stefan K.L.

Role Chief Investment Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	9,151	$0.00	$0.00
Exercise	Restricted Stock Unit	5,086	$0.00	$0.00
Grant/Award	Restricted Stock Unit	9,510	$0.00	$0.00
Exercise	Common Stock	9,151	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	4,657	$48.25	$225K
Exercise	Common Stock	5,086	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	2,588	$48.25	$125K

Holdings After Transaction: Restricted Stock Unit — 28,836 shares (Direct); Common Stock — 95,430 shares (Direct)

Footnotes (5)

F1. Each restricted stock unit ("RSU") converts into one share of the Issuer's common stock.
F2. Shares withheld by the Issuer to satisfy the Reporting Person's tax obligations associated with the vesting of time-based RSUs on March 25, 2026.
F3. On March 25, 2024, the Issuer awarded the Reporting Person 27,454 time-based RSUs. The RSUs vest ratably on March 25, 2025, 2026 and 2027 (subject to continuous employment through each vesting date).
F4. On March 25, 2025, the Issuer awarded the Reporting Person 15,260 time-based RSUs. The RSUs vest ratably on March 25, 2026, 2027 and 2028 (subject to continuous employment through each vesting date).
F5. On March 25, 2026, the Issuer awarded the Reporting Person 9,510 time-based RSUs. The RSUs will vest ratably on March 10, 2027, 2028 and 2029 (subject to continuous employment through each vesting date).

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/27/2026 - 04:32 PM

FAQ

What insider transactions did AHR Chief Investment Officer Stefan Oh report?

Stefan Oh reported vesting of two restricted stock unit blocks that converted into 9,151 and 5,086 common shares, a tax-related share withholding, and a new grant of 9,510 restricted stock units, reflecting routine compensation rather than discretionary market trading.

Did AHR’s Stefan Oh sell any shares on the open market in this Form 4?

No open‑market sales were reported. Shares labeled with code F, totaling 4,657 and 2,588 at $48.25, were withheld by the company solely to satisfy Mr. Oh’s tax obligations from vesting restricted stock units, not discretionary stock sales.

How many AHR common shares does Stefan Oh hold after these transactions?

After the reported transactions, Stefan Oh directly holds 95,430 shares of American Healthcare REIT common stock. This figure already reflects the newly issued shares from restricted stock unit vesting and the shares withheld to cover associated tax liabilities.

What new equity award did AHR grant to Stefan Oh in this filing?

American Healthcare REIT granted Stefan Oh 9,510 time‑based restricted stock units on March 25, 2026. According to the disclosure, these units will vest in equal installments on March 10, 2027, 2028 and 2029, subject to his continued employment through each vesting date.

How many restricted stock units vested for AHR’s Stefan Oh on March 25, 2026?

Two prior restricted stock unit awards partially vested, converting 9,151 and 5,086 units into common stock on March 25, 2026. Each vested unit converted into one share of American Healthcare REIT common stock, consistent with the one‑for‑one RSU conversion terms disclosed.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Oh Stefan K.L.

(Last)

(First)

(Middle)

18191 VON KARMAN AVENUE

THIRD FLOOR

(Street)

IRVINE

CALIFORNIA

92612

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
American Healthcare REIT, Inc. [ AHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Investment Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/25/2026		M		9,151	A	⁽¹⁾	97,589	D
Common Stock	03/25/2026		F		4,657⁽²⁾	D	$48.25	92,932	D
Common Stock	03/25/2026		M		5,086	A	⁽¹⁾	98,018	D
Common Stock	03/25/2026		F		2,588⁽²⁾	D	$48.25	95,430	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	⁽¹⁾	03/25/2026		M			9,151	⁽³⁾	⁽³⁾	Common Stock	9,151	$0	9,152	D
Restricted Stock Unit	⁽¹⁾	03/25/2026		M			5,086	⁽⁴⁾	⁽⁴⁾	Common Stock	5,086	$0	10,174	D
Restricted Stock Unit	⁽¹⁾	03/25/2026		A		9,510		⁽⁵⁾	⁽⁵⁾	Common Stock	9,510	$0	9,510	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") converts into one share of the Issuer's common stock.

2. Shares withheld by the Issuer to satisfy the Reporting Person's tax obligations associated with the vesting of time-based RSUs on March 25, 2026.

3. On March 25, 2024, the Issuer awarded the Reporting Person 27,454 time-based RSUs. The RSUs vest ratably on March 25, 2025, 2026 and 2027 (subject to continuous employment through each vesting date).

4. On March 25, 2025, the Issuer awarded the Reporting Person 15,260 time-based RSUs. The RSUs vest ratably on March 25, 2026, 2027 and 2028 (subject to continuous employment through each vesting date).

5. On March 25, 2026, the Issuer awarded the Reporting Person 9,510 time-based RSUs. The RSUs will vest ratably on March 10, 2027, 2028 and 2029 (subject to continuous employment through each vesting date).

	/s/ STEFAN K.L. OH	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR